Time course of systemic inflammatory markers during acute exacerbation of COPD Source: Eur Respir J 2007; 30: Suppl. 51, 555s Year: 2007
Leptin and inflammatory cytokines during COPD exacerbation Source: Eur Respir J 2002; 20: Suppl. 38, 252s Year: 2002
Plasma biomarkers and response to therapy at exacerbation of COPD Source: Eur Respir J 2007; 30: Suppl. 51, 39s Year: 2007
Neutrophil apoptosis and systemic inflammatory markers in acute exacerbation of COPD Source: Eur Respir J 2003; 22: Suppl. 45, 572s Year: 2003
Systemic inflammatory response in relation to disease severity and nutritional depletion in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 31s Year: 2004
The level of anti-inflammatory cytokine IL-10 in patients with chronic obstructive pulmonary disease of varying severity Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013
Cachexia in patients with acute COPD exacerbations: relationship to pulmonary function, systemic inflammation and oxidative stress Source: Annual Congress 2008 - Comorbidities in COPD Year: 2008
Determinants of heightened systemic inflammation at exacerbation of COPD Source: Eur Respir J 2006; 28: Suppl. 50, 115s Year: 2006
Differences in biomarkers of systemic inflammation in two phenotypes of COPD patients Source: Annual Congress 2011 - COPD: human studies Year: 2011
Systemic inflammation and systemic oxidative stress in patients with acute exacerbations of COPD Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007
Inflammation biomarkers of lung tissue damage in acute exacerbation of COPD patients Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013
Systemic inflammation and systemic oxidative stress in acute COPD exacerbation Source: Annual Congress 2010 - Novel markers of lung injury Year: 2010
Alterations in sputum inflammatory markers during exacerbations for COPD patients with different stable state levels Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019
Temporal profile and clinical utility of inflammatory markers in patients with acute exacerbation of COPD Source: Annual Congress 2008 - Structural remodelling in COPD Year: 2008
Endothelial dysfunction and systemic inflammation during acute exacerbations of COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016
Influence of infection and α1-proteinase inhibitor on inflammatory response in COPD exacerbation Source: Eur Respir J 2003; 22: Suppl. 45, 417s Year: 2003
Serum angiopoietin-2 levels in stable and exacerbated chronic obstructive pulmonary disease Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema Year: 2015
The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease Source: Eur Respir J 2007; 30: Suppl. 51, 363s Year: 2007
The assesment of serum TNFα levels in COPD acute exacerbation and the effects of inhaler steroids on clinical and inflammatory determinants Source: Eur Respir J 2002; 20: Suppl. 38, 312s Year: 2002